Dudediligence.

Lexaria Bioscience Corp

LEXXNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: S-3, Shelf registrationOct 1 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: PTN, ARTL, IONS→

From the filings

Figures

Revenue
$194,000last 12 months
Net income
−$7.7Mlast 12 months
Operating cash flow
−$9.4Mlast 12 months
Cash and equivalents
$3.5Mat the last balance sheet
Shares outstanding
24.8M shareson issue
Every year and quarter →